Literature DB >> 25639818

Can QT/RR relationship differentiate between low- and high-risk patients with hypertrophic cardiomyopathy?

Ricardo A Quinteiro1, Marcelo O Biagetti1, Adrian Fernandez2, Francisco R Borzone1, Agustina Gargano2, Horacio J Casabe2.   

Abstract

BACKGROUND: Abnormal dynamicity of repolarization is considered to be a marker of myocardial vulnerability contributing to increased risk of arrhythmic events and sudden death. However, little is known about QT dynamics in hypertrophic cardiomyopathy (HCM). In this study, we aimed to evaluate ventricular repolarization by QT dynamicity in patients with HCM, focusing on its value to define if it is able to differentiate among low- and high-risk HCM patients.
METHODS: The linear regression slopes of the QT interval, measured to the apex and to the end of the T wave plotted against RR intervals (QTapex/RR and QTend/RR slopes, respectively) were calculated from 24-hour Holter recordings using a standard algorithm in 36 HCM patients and 64 control subjects.
RESULTS: QTapex/RR and QTend/RR slopes were significantly steeper in the HCM patients in contrary to healthy control subjects (QTapex/RR = 0.22 + 0.08 vs 0.20 + 0.05, P = 0.0367; QTend/RR = 0.25 + 0.10 vs 0.20 + 0.06, P = 0.023). Moreover, the slopes of QTend/RR and QTapex/RR of high-risk patients were significantly steeper than those of control subjects while no significant differences were found among low-risk HCM patients and control subjects and only QTe/RR of high-risk patients was significantly different between low- and high-risk HCM patients.
CONCLUSIONS: Our study results suggest that QT dynamicity is impaired in patients with HCM and may help to differentiate among low- and high-risk patients. Further studies are needed to elucidate the prognostic significance and clinical implications of impaired ventricular repolarization in patients with HCM.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  noninvasive techniques-Holter/event recorders; noninvasive techniques-QT dispersion

Mesh:

Year:  2015        PMID: 25639818      PMCID: PMC6931755          DOI: 10.1111/anec.12230

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  23 in total

1.  Circadian modulation of QT rate dependence in healthy volunteers: gender and age differences.

Authors:  F Extramiana; P Maison-Blanche; F Badilini; J Pinoteau; T Deseo; P Coumel
Journal:  J Electrocardiol       Date:  1999-01       Impact factor: 1.438

2.  The telemetric and Holter ECG warehouse initiative (THEW): a data repository for the design, implementation and validation of ECG-related technologies.

Authors:  Jean-Philippe Couderc
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

Review 3.  Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  Circulation       Date:  2010-01-26       Impact factor: 29.690

4.  Can the assessment of dynamic QT dispersion on exercise electrocardiogram predict sudden cardiac death in hypertrophic cardiomyopathy?

Authors:  G Yi; J Poloniecki; S Dickie; P M Elliott; M Malik; W J McKenna
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

5.  QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.

Authors:  Gianfranco Piccirillo; Giuseppe Germanò; Raffaele Quaglione; Marialuce Nocco; Filippo Lintas; Marco Lionetti; Antonio Moisè; Maddalena Ragazzo; Vincenzo Marigliano; Mauro Cacciafesta
Journal:  Clin Sci (Lond)       Date:  2002-03       Impact factor: 6.124

Review 6.  Cellular basis for the repolarization waves of the ECG.

Authors:  Charles Antzelevitch
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

7.  Measure of the QT-RR dynamic coupling in patients with the long QT syndrome.

Authors:  Josef Halamek; Jean-Philippe Couderc; Pavel Jurak; Vlastimil Vondra; Wojciech Zareba; Ivo Viscor; Pavel Leinveber
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

8.  Hypertrophic cardiomyopathy: electrical abnormalities detected by the extended-length ECG and their relation to syncope.

Authors:  Giuseppe Barletta; Chiara Lazzeri; Franco Franchi; Riccarda Del Bene; Antonio Michelucci
Journal:  Int J Cardiol       Date:  2004-10       Impact factor: 4.164

9.  Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG.

Authors:  Akira Fujiki; Ryozo Yoshioka; Masao Sakabe
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

10.  Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure.

Authors:  Iwona Cygankiewicz; Wojciech Zareba; Rafael Vazquez; Jesus Almendral; Antoni Bayes-Genis; Miquel Fiol; Mariano Valdes; Carlos Macaya; Jose R Gonzalez-Juanatey; Juan Cinca; Antoni Bayes de Luna
Journal:  J Cardiovasc Electrophysiol       Date:  2008-06-28
View more
  3 in total

1.  Fibrosis and wall thickness affect ventricular repolarization dynamics in hypertrophic cardiomyopathy.

Authors:  Mikko Jalanko; Heikki Väänänen; Mika Tarkiainen; Petri Sipola; Pertti Jääskeläinen; Kirsi Lauerma; Tiina Laitinen; Tomi Laitinen; Mika Laine; Tiina Heliö; Johanna Kuusisto; Matti Viitasalo
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-07-04       Impact factor: 1.468

Review 2.  Ventricular repolarization measures for arrhythmic risk stratification.

Authors:  Francesco Monitillo; Marta Leone; Caterina Rizzo; Andrea Passantino; Massimo Iacoviello
Journal:  World J Cardiol       Date:  2016-01-26

3.  Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Alan Sugrue; Ammar M Killu; Christopher V DeSimone; Anwar A Chahal; Josh C Vogt; Vaclav Kremen; JoJo Hai; David O Hodge; Nancy G Acker; Jeffrey B Geske; Michael J Ackerman; Steve R Ommen; Grace Lin; Peter A Noseworthy; Peter A Brady
Journal:  Open Heart       Date:  2017-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.